OR WAIT null SECS
© 2023 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2023 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Examining new approaches, novel technologies, and the structural evolution of the raw materials market.
Advancements in soft capsule technology can enable the development of soft capsule formulations.
Alternative drug delivery formulation strategies can remove some drug dosage forms limitations.
March 17, 2023
Sandoz, a Novartis division, is expected to invest at least $400 million to build a new biologics manufacturing facility in Lendava, Slovenia, to support growing demand for biosimilars.
March 07, 2023
In this episode, Rhonda Henry and Adam Mendizabal from Emmes discuss the role CROs play in cell and gene therapies undergoing clinical trials at all stages.
March 03, 2023
This article discusses the evaluation of paired content uniformity and weight variation data sets using F and T tests to ensure that batches meet compendial requirements.
Advancements in therapeutic modalities are necessitating change in drug delivery to help negate some of the expense of development and manufacturing.
EnteroBiotix is harnessing the power of the microbiome to target an array of diseases.
March 02, 2023
Lilly will cap insulin prices for patients with and without insurance at $35 per month.
February 22, 2023
Quotient Sciences’ facility expansion is designed to increase support for fully integrated drug development programs.
February 17, 2023
In this paper, the authors lay out some commonly accepted HCP analytical methods, the challenges of HCP assay, and provide recommendations on what can easily be accomplished in-house and when it may be better to outsource.
February 15, 2023
Shifting toward more technological solutions and ensuring a greater understanding of the workforce’s needs will give both CROs and sponsors a market advantage.
February 03, 2023
Efforts to optimize the delivery of sensitive biotherapeutics continue to evolve.